Age Related Macular Degeneration (AMD) can cause people to lose central vision and is a leading cause of vision
loss in seniors. The
prompt treatment of “Wet” Macular Degeneration is very helpful in preventing
catastrophic vision loss for most patients. The “Wet” form of AMD is
currently treated by repeated injections into the eye of drugs called Vascular
Endothelial Growth Factor (VEGF) inhibitors-that stop, reverse and prevent new
blood vessel growth. The most common VEGF inhibitors include Lucentis®, Eylea®
and Avastin® and often require monthly injections to be effective. Researchers
from the University of Birmingham (UK) Institute Inflammation and Aging reporting
in the journal Investigative Ophthalmology & Visual Science have developed a method of
delivering the AMD treatment drugs via an eye drop rather than by injection.
The eye drop uses a molecule
called a cell–penetrating peptide (CPP) to deliver the drug to the relevant
part of the eye and hold future promise for treating Age Relater Macular
Degeneration (AMD) with eye drops rather than injections.
If you or someone you know
has a family history of Age Related Macular Degeneration (AMD) and is over 50
years of age or is a senior who has not had regular eye exams, please schedule
and eye exam to help us help you avoid vision loss. Please call D’Ambrosio
Eye Care at 800-325-3937, visit D’Ambrosio Eye Care, Google+ or facebook.com/dambrosioeyecare so that
we can help.
D'Ambrosio Eye Care provides eye care for patients
throughout greater Boston, central and western Massachusetts with office
locations at 479 Old Union Turnpike, Lancaster, Massachusetts 01523, 865
Merriam Avenue, Suite 119, Leominster, Massachusetts 01453, 100 Powder Mill
Road, Acton, Massachusetts 01720, 413 Main Street, Athol, Massachusetts 01331
and 74 Main Street, Gardner, Massachusetts 01440.
